NCT02953548 - Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

May 7, 2018

Study Completion Date

May 7, 2018

Conditions

Infantile Spasms

Interventions

DRUG

GWP42003-P

Clear, colorless to yellow solution containing cannabidiol dissolved in the excipients sesame oil and anhydrous ethanol with added sweetener (sucralose) and strawberry flavoring.

Trial Locations (8)

22601

Valley Health Clinical Research, Winchester

27157

Wake Forest Baptist Medical Center, Winston-Salem

38103

Le Bonheur Children's Hospital, Memphis

43205

Nationwide Children's Hospital, Columbus

72202

Arkansas Children's Hospital, Little Rock

78207

The Childrens Hospital of San Antonio, San Antonio

Unknown

Uniwersyteckie Centrum Kliniczne, Gdansk

Centrum Medyczne POMOC, Lodz